Insider · CIK 0002007485
Jens Kemp
officer
Files at AXGN (Axogen, Inc.). First filing Dec 10, 2025, latest Dec 10, 2025.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 1
$0 bought, $255k sold
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
AXGN: Axogen, Inc.
AXGNOct 9, 2026 · close 36.13
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 48Moderate | Axogen, Inc. | $255k 8,156 shares | -15% | +229% from low-8% from high |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Dec 9, 2025 | AXGN Axogen, Inc. | SOpen-market sale Common Stock | -8,156 | $31.21 | $255k | 46,030 | Dec 10, 2025 |
| Dec 4, 2025 | AXGN Axogen, Inc. | AGrant or award Common Stock | +22,500 | $0.00 | $0 | 54,186 | Dec 5, 2025 |
| Mar 25, 2025 | AXGN Axogen, Inc. | AGrant or award Restricted Stock Unitsderivative | +38,000 | $0.00 | $0 | 38,000 | Mar 26, 2025 |
| Mar 4, 2025 | AXGN Axogen, Inc. | FTax withholding Common Stock | -4,003 | $18.36 | $73k | 27,683 | Mar 5, 2025 |
| Feb 22, 2025 | AXGN Axogen, Inc. | MOption exercise Common Stock | +2,500 | $0.00 | $0 | 2,500 | Feb 26, 2025 |
| Feb 25, 2025 | AXGN Axogen, Inc. | FTax withholding Common Stock | -814 | $16.49 | $13k | 1,686 | Feb 26, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.